Plain-English translation of NCT06913907 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study is following people with rheumatoid arthritis who are starting methotrexate for the first time. Researchers want to understand how your body processes and uses methotrexate when you take it as a pill versus when you receive it as an injection under the skin. By measuring specific markers in your blood, they hope to learn whether switching to the injection form allows doctors to safely use higher doses of the medication.
Methotrexate is an effective treatment for rheumatoid arthritis, but doctors don't fully understand how the body uses it differently depending on whether you take a pill or get an injection. This information could help doctors personalize your treatment and potentially improve how well the medication works for you.
You likely qualify if…
You likely don't qualify if…
You will start taking methotrexate as a pill, and researchers will measure how your body processes it by taking blood samples from you. Over time, you may switch to receiving the same medication as an injection under your skin, and they will continue monitoring your blood to see how your body processes it differently. Throughout the study, doctors will assess how well the medication is working for your arthritis and watch for any side effects.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Japan